November 3, 2025 Celebrating a Decade of Impact: Critical Path for Parkinson’s 10-Year Impact Report Now Available Critical Path for Parkinson’s (CPP), a global public-private partnership led by C-Path...
October 16, 2025 C-Path’s Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub Critical Path Institute® (C-Path) today announced the official launch of the Critical Path Disease...
October 7, 2025 C-Path CEO Romero Featured in Scientific American Feature The piece explores the concept of healthspan — the years of life lived free from serious disease — a topic gaining momentum...
October 7, 2025 C-Path Rare/0rphan and Pediatric Disease Programs Q3 2025 Newsletter Now Available Welcome to the Rare/Orphan and Pediatric Disease Programs quarterly newsletter. In between major announcements...
October 7, 2025 C-Path Rare/0rphan and Pediatric Disease Programs Q3 2025 Newsletter Now Available Welcome to the Rare/Orphan and Pediatric Disease Programs quarterly newsletter. In between major announcements...
September 11, 2025 C-Path Concludes 2025 Global Impact Conference with Progress Across Rare Diseases, Neurology and Pediatrics Global regulators, industry leaders, scientists, and patient advocates set near-term commitments on early interception...
September 10, 2025 C-Path’s Global Impact Conference | Every Stage, Every Step: Transforming Lives Through Optimized Drug Development | Day 2 Recap Day 2 of the C-Path Global Impact Conference built on the momentum of opening day...
September 9, 2025 C-Path’s Global Impact Conference | Every Stage, Every Step: Transforming Lives Through Optimized Drug Development | Day 1 Recap Day 1 of Critical Path Institute's Global Impact Conference, #CGIC2025, opened with powerful conversations on accelerating...
September 4, 2025 C-Path’s Translational Therapeutics Accelerator Marks Record Year with Seven BRIDGe Awards Advancing Potential Therapies Across Cancer, Infectious Disease, Neurology and Immunology Program launched in 2022 has grown into a global pipeline partner for academic teams, awarding approximately $2.48 million...
August 21, 2025 HDYO Joins C-Path’s Huntington’s Disease Consortium to Amplify Youth Voices in Drug Development TUCSON, Ariz., August 21, 2025 — Critical Path Institute’s® (C-Path) Huntington’s Disease Regulatory Science Consortium...